GKB Ophthalmics Share Price Today | Stock Price & GKB Ophthalmics Share Screener
As of October 5, 2026, the live GKB Ophthalmics share price (NSE: GKB) is ₹62.96 on NSE and ₹59.64 on BSE, down 2.18% from the previous close, with shares trading between ₹61.00 and ₹67.00 in today's trading session, and a 52-week range of ₹60.90–₹71.52. Check GKB 52-week high low for the annual price range and momentum. Use the GKB Ophthalmics stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today GKB Ophthalmics opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹31 and net income of ₹1, with EBITDA of ₹2, an operating margin of 5.0% and a profit margin of 3.2%.
GKB Ophthalmics Share Price Chart
Track the current stock price of GKB Ophthalmics with an interactive chart. Analyse GKB share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete GKB Ophthalmics stock quote in one place.
The quote of ₹62.96 sits between the 52-week low of ₹60.90 and the 52-week high of ₹71.52, and the latest session moved -2.18% from the previous close.
GKB Ophthalmics Company Profile - Fundamental Screener
Screen GKB Ophthalmics company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for GKB shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Medical Equipment industry, and it trades under ISIN INE265D01015.
Company Details
Classification
Identifiers and Leadership
GKB Ophthalmics Balance Sheet Screener
Screen GKB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹132, up from ₹125 in 2025.
Latest statistics put total assets at ₹132 and shareholder funds at ₹55, with a leverage ratio of 0.25.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 132 | 125 | 115 | 112 | 110 | 107 | 102 | 93 | 83 | 82 |
| Current Assets | 108 | 99 | 88 | 84 | 76 | 74 | 73 | 64 | 64 | 63 |
| Fixed Assets | 15 | 17 | 18 | 19 | 23 | 24 | 26 | 26 | 18 | 18 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 6 | 6 | 4 | 4 | 4 | 2 | 2 | 2 | 2 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 55 | 56 | 64 | 67 | 67 | 66 | 59 | 55 | 45 | 47 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| Reserves & Surplus | 48 | 47 | 55 | 58 | 58 | 58 | 54 | 47 | 41 | 43 |
GKB Ophthalmics Income Statement Screener - Profit & Revenue Analysis
Screen GKB Ophthalmics income statement and profit fundamentals. Analyze GKB quarterly results. GKB Ophthalmics reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Mar, revenue was ₹31 and net profit was ₹1, equal to earnings per unit of ₹0.38, at an operating margin of 5%.
In that period expenses were ₹28, interest cost ₹1 and tax ₹0. The next period listed, 2026-Jun, shows revenue of ₹34 and net profit of ₹2.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 31 | 34 | 31 | 33 | 31 | 58 | 22 | 26 | 26 | 26 | 20 | 23 | 21 | 24 | 18 |
| Expenses | 28 | 30 | 34 | 32 | 27 | 55 | 22 | 25 | 26 | 27 | 20 | 21 | 21 | 25 | 16 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 2 | 3 | -3 | 1 | 3 | 2 | 1 | 1 | 0 | -1 | 0 | 2 | 0 | 0 | 2 |
| Operating Profit % | 5.00% | 8.00% | -9.00% | 2.00% | 10.00% | 2.00% | 0.00% | 4.00% | 0.00% | -4.00% | -2.00% | 6.00% | -1.00% | -3.00% | 9.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 1 | 2 | -4 | -1 | 2 | 1 | -1 | 0 | -1 | -2 | -2 | 1 | -1 | -1 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 2 | -4 | -1 | 2 | 1 | -1 | 0 | -1 | -2 | -2 | 1 | -1 | -1 | 1 |
| EPS | 0.38 | 2.00 | -7.03 | -2.02 | 3.17 | 0.08 | -1.81 | -0.50 | -2.41 | -4.03 | -3.80 | 1.04 | -2.32 | -2.48 | 1.29 |
GKB Ophthalmics Cash Flow Screener - Liquidity Fundamentals
Screen GKB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities used ₹4.
Over the same period, investing activities provided ₹9 and financing activities used ₹6.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | -4 | -3 | 4 | -3 | 5 | 7 | 3 | 4 | -3 | -3 |
| Investing Activities | 9 | 3 | -2 | 1 | -4 | -17 | -4 | -10 | 1 | 4 |
Financing and Net Cash | ||||||||||
| Financing Activities | -6 | 1 | -2 | -2 | -2 | 3 | 4 | 13 | 1 | -1 |
| Net Cash Flow | 0 | 0 | 1 | -4 | 0 | -7 | 4 | 7 | 0 | -1 |
GKB Ophthalmics Shareholding Pattern Screener
See GKB Ophthalmics shareholding pattern with promoter, FII, and DII holdings. Check GKB Ophthalmics promoter holding and ownership changes for GKB on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 51.13%, foreign institutions 1.79%, domestic institutions 0.00% and the public 38.52%, spread across 2,634 shareholders.
The shareholder count was 2,634 in 2026-Mar, compared with 2,557 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 51.13% | 51.15% | 50.99% | 51.06% | 51.06% | 51.13% | 50.93% | 50.95% |
Institutional Investors | ||||||||
| FII Holding | 1.79% | 1.79% | 1.79% | 1.79% | 1.79% | 1.79% | 1.79% | 1.79% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 38.52% | 38.97% | 37.36% | 37.22% | 37.23% | 38.55% | 36.04% | 36.64% |
| Other Holding | 8.57% | 8.09% | 9.87% | 9.94% | 9.93% | 8.53% | 11.23% | 10.63% |
| Shareholder Count | 2,634 | 2,557 | 2,538 | 2,550 | 2,601 | 2,661 | 2,370 | 2,690 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by GKB Ophthalmics. GKB Ophthalmics dividend yield can be compared with peers and other stocks in the market.
GKB Ophthalmics Stock Index Membership - Nifty & Sensex
See which indices include GKB Ophthalmics stock. Check GKB index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
GKB Ophthalmics Market Events Screener - Corporate Actions
Get GKB Ophthalmics corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check GKB Ophthalmics stock events that may affect GKB share price, along with derivatives, futures and options activity and sector gainers.
12 corporate actions are listed, the most recent entry being Annual General Meeting dated September 25, 2026, with a record date of September 25, 2026.
It is followed by Annual General Meeting dated August 25, 2026 and Quarterly Result Announcement dated August 12, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-25 | 2026-09-25 | Annual General Meeting | NA | -1.43% |
| 2026-08-25 | 2026-08-25 | Annual General Meeting | NA | 13.45% |
| 2026-08-12 | 2026-08-12 | Quarterly Result Announcement | NA | 4.35% |
| 2026-05-27 | 2026-05-27 | Quarterly Result Announcement | NA | -0.93% |
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | 0.63% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -11.47% |
| 2025-08-21 | 2025-08-21 | Annual General Meeting | NA | 9.47% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | -1.78% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 4.58% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -1.18% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -1.14% |
| 2024-08-20 | 2024-08-20 | Annual General Meeting | NA | 24.77% |
GKB Ophthalmics Competitors Screener - Peer Stocks Comparison
Screen GKB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Poly Medicure | 16,590 | 55.86 | 1,995 | 13.43% | 321 | 36.79 |
| Tarsons Products | 1,798 | 158.95 | 447 | 9.38% | 14 | 56.69 |
| Q-Line Biotech | 1,555 | 27.98 | 342 | 5.93% | 56 | 55.51 |
| Laxmi Dental | 1,059 | 35.55 | 286 | 18.15% | 26 | 40.70 |
| Hemant Surgical Industries | 851 | 49.26 | 238 | 112.99% | 18 | 70.82 |
| Vasa Denticity | 737 | 63.59 | 283 | 12.77% | 10 | 59.90 |
| Osel Devices | 685 | 23.50 | 295 | 57.88% | 29 | 51.02 |
| Fabtech Technologies | 641 | 13.37 | 411 | 22.29% | 36 | 38.45 |
| Prevest Denpro | 456 | 21.00 | 77 | 14.31% | 21 | 46.65 |
| QMS Medical Allied Services | 399 | 30.21 | 174 | 10.27% | 12 | 83.35 |
GKB Ophthalmics Company Announcements - News & Reports Screener
Screen GKB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated .
The next most recent announcements are dated September 29, 2026 and August 26, 2026.
| Date | Update | Actions |
|---|---|---|
| Closure of Trading Window | - | |
| 2026-09-29 | Submission Of Minutes Of 44Th Annual General Meeting Of The Company Held On 25Th August 2026. | - |
| 2026-08-26 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-08-25 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-12 | Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026. | - |
| 2026-08-12 | Board Meeting Outcome for Outcome Of The Board Meeting Of GKB Ophthalmics Ltd. Held On August 12 2026 | - |
| 2026-08-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-31 | Disclosure Of Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015("Listing Regulations) | - |
| 2026-07-31 | Notice For Book Closure | - |
| 2026-07-31 | Reg. 34 (1) Annual Report. | - |
| 2026-07-25 | Board Meeting Intimation for Approval Of Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026 | - |
| 2026-07-14 | Disclosure Of Information Pursuant To Regulation 30- Update On Case No. 32/09 Filed For Adjudication Of Charter Of Demands | - |
| 2026-07-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-30 | Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015 | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-06-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-27 | Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31 2026 | - |
| 2026-05-27 | Board Meeting Outcome for GKB_Outcome Of The Board Meeting Held On May 27 2026 | - |
| 2026-05-27 | Announcement under Regulation 30 (LODR)-Credit Rating | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹62.96, within a 52-week range of ₹60.90 to ₹71.52. The P/E ratio is 6.27 and the P/B ratio is 0.65, with earnings per unit of ₹-7.08. Market capitalisation stands at ₹32.95 Cr. The company operates in the Healthcare sector, in the Medical Equipment industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.